Get the Stockscreener App
1.47
5.00%
0.07
After Hours:
1.48
0.01
+0.68%
Cibus Inc stock is traded at $1.47, with a volume of 97,458.
It is up +5.00% in the last 24 hours and up +8.09% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$1.40
Open:
$1.4
24h Volume:
97,458
Relative Volume:
0.50
Market Cap:
$79.73M
Revenue:
$1.82M
Net Income/Loss:
$-267.63M
P/E Ratio:
-0.0729
EPS:
-20.1639
Net Cash Flow:
$-50.53M
1W Performance:
-1.34%
1M Performance:
+8.09%
6M Performance:
-18.78%
1Y Performance:
-60.27%
1-Day Range:
$1.3705
$1.50
1-Week Range:
$1.3527
$1.54
52-Week Range:
$1.20
$6.10
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.47 | 73.56M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Institutional scanner results for Cibus Inc.July 2025 Closing Moves & Momentum Based Trading Signals - newser.com
Can you recover from losses in Cibus Inc.2025 Investor Takeaways & Real-Time Sentiment Analysis - newser.com
Sentiment analysis tools applied to Cibus Inc.July 2025 Gainers & Free Real-Time Volume Trigger Notifications - newser.com
Is Cibus Inc. meeting your algorithmic filter criteriaEarnings Overview Summary & Capital Protection Trade Alerts - newser.com
Custom watchlist performance reports with Cibus Inc.Buy Signal & Accurate Entry and Exit Point Alerts - newser.com
How Cibus Inc. stock performs in stagflationGap Up & Weekly Momentum Stock Picks - newser.com
Exit strategy if you’re trapped in Cibus Inc.July 2025 Decliners & Short-Term Trading Opportunity Alerts - newser.com
How to recover losses in Cibus Inc. stockMarket Activity Recap & Accurate Intraday Trading Signals - newser.com
Origin Agritech (NASDAQ:SEED) versus Cibus (NASDAQ:CBUS) Head to Head Analysis - Defense World
What’s next for Cibus Inc. stock pricePortfolio Gains Summary & Low Risk High Win Rate Picks - newser.com
Tick level data insight on Cibus Inc. volatilityPortfolio Value Summary & Weekly Chart Analysis and Trade Guides - newser.com
Cibus Inc. recovery potential after sell offJuly 2025 Gainers & Community Supported Trade Ideas - newser.com
Cibus' (CBUS) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Can Cibus Inc. stock deliver sustainable ROEJuly 2025 Big Picture & AI Enhanced Trading Alerts - newser.com
Head to Head Contrast: Corteva (NYSE:CTVA) versus Cibus (NASDAQ:CBUS) - Defense World
Intraday pattern recognizer results for Cibus Inc.July 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Why Cibus Inc. is moving today2025 Year in Review & Free Expert Verified Stock Movement Alerts - newser.com
Tools to assess Cibus Inc.’s risk profile2025 Top Gainers & Smart Allocation Stock Tips - newser.com
Using Ichimoku Cloud for Cibus Inc. technicalsJuly 2025 Update & Technical Pattern Alert System - newser.com
How sentiment analysis helps forecast Cibus Inc.Market Growth Summary & Weekly Top Gainers Trade List - newser.com
Cibus Completes Field Testing of Second-Generation Herbicide Tolerance Canola - iGrow News
Cibus completes field testing of second-gen herbicide tolerance edited Canola - TipRanks
Cibus (CBUS) Advances Canola Field Trials with Promising Results - GuruFocus
Cibus Announces Positive Field Trial Results for Second-Generation Herbicide Tolerance (HT2) Edited Canola - The Manila Times
Cibus, Inc. Announces Successful Field Testing of HT2 Herbicide Tolerance Trait in Canola for Commercial Licensing - Quiver Quantitative
Next-Gen Herbicide Tolerance: Cibus's Gene-Edited Canola Breakthrough Promises Better Weed Control - Stock Titan
Using flow based indicators on Cibus Inc.Treasury Yields & High Accuracy Trade Signal Alerts - newser.com
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cibus Inc Stock (CBUS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Prante Gerhard | Director |
Feb 24 '25 |
Sale |
2.07 |
1,150 |
2,380 |
8,857 |
| Prante Gerhard | Director |
Feb 21 '25 |
Sale |
2.20 |
1,150 |
2,530 |
10,007 |
| Prante Gerhard | Director |
Feb 20 '25 |
Sale |
2.35 |
1,150 |
2,702 |
11,157 |
| Prante Gerhard | Director |
Feb 19 '25 |
Sale |
2.58 |
1,150 |
2,967 |
12,307 |
| Prante Gerhard | Director |
Feb 18 '25 |
Sale |
2.52 |
2,300 |
5,796 |
13,457 |
| Prante Gerhard | Director |
Feb 14 '25 |
Sale |
2.60 |
1,150 |
2,990 |
15,757 |
| Prante Gerhard | Director |
Feb 13 '25 |
Sale |
2.53 |
1,150 |
2,910 |
16,907 |
| Prante Gerhard | Director |
Feb 12 '25 |
Sale |
2.45 |
1,150 |
2,818 |
18,057 |
| Prante Gerhard | Director |
Feb 11 '25 |
Sale |
2.48 |
1,150 |
2,852 |
19,207 |
| Prante Gerhard | Director |
Feb 10 '25 |
Sale |
2.52 |
1,150 |
2,898 |
20,357 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):